SABM James D. Ferguson, Keith A. Samolyk, Victor Carcioppolo ...

13. Shann, K. G., Likosky, D. S., Murkin, J. M., Baker, R. A., Baribeau, Y. R., &
DeFoe, G. R. et al. (2006). An evidence-based review of the practice of
cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic
control, hemodilution, and the inflammatory response. The Journal of
Thoracic and Cardiovascular Surgery , 132, 283-293.
14. Takayama, H., Soltow, L. O., & Aldea, G. S. (2007). Differential expression in
markers for thrombin, platelet activation, and inflammation in cell saver
versus systemic blood in patients undergoing on-pump coronary artery bypass
graft surgery. Journal of Cardiothoracic and Vascular Anesthesia, 21, 519-523.
15. Van den Goor, J. M., Nieuwland , R., Rutten, P. M., Tijssen, J. G., Hau, C., &
Sturk, A. et al. (2007). Retransfusion of pericardial blood does not trigger
systemic coagulation during cardiopulmonary bypass. European Journal of
Cardio-thoracic Surgery, 31, 1029-1036.
16. Vertrees, R. A., Conti, V. R., Lick, S. D., Zwischenberger, J. B., McDaniel, L.
B., & Shulman, G. (1996). Adverse effects of postoperative infusion of shed
mediastinal blood . Annals of Thoracic Surgery, 62, 717-723.
17. Wang, G., Brainbridge, D., Martin, J., & Cheng, D. (2009). The efficacy of an
intraoperative cell saver during cardiac surgery: A meta-analysis of
randomized trials. Anesthesia and Analgesia, 109, 320-330.
18. Waters, J. H. (2004). Indications and contraindications of cell salvage.
Transfusion, 44, 40S-44S.